Cannabis and Hemp Industry Investment News
It signed a deal with the Alberta Gaming, Liquor & Cannabis Commission to supply its Captain’s Choice and Royal High line of products United Green...
The test helps individuals to pick more personalized cannabis products and help them choose formulation, dosage and the best delivery method for their...
BioTrackTHC’s more than 2,000 point of sale customer locations will be able to offer Jane’s automated, fully customizable ordering platform The integr...
What are you searching for? The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.2% at 113 points. El...
The analytics assets would go into a special purpose entity, named BioScience NewCo, that would be operated as a stand-alone firm "Having invested sub...
The Toronto-based company partnered with the first Colombian cannabis company to be fully licensed in cultivation Also moving were Charlotte's Web, Au...
The company will work to create market access and design clinical trials to support the deployment of new FCM cannabinoid-based products CEO Prad Seka...
Corp (), formerly Primary Energy Metals Inc () (OTCMKTS:PEMTD), announced Tuesday that it has completed the acquisition of Columbian cannabis producer...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Inc (), the bioprotection and plant health company, is...
Late last month, the company had entered into an agreement with a syndicate of underwriters to raise C$22 million TGOD plans to use the money to compl...
It paid Passport Technology $4,175,000 which includes $375,000 in cash, and 5 million in shares of Body and Mind, and some Australis stock Focused on ...
The deal gives CannMart Labs its own license to use Phyto trademarks on an array of cannabis products Namaste will add Phyto’s suite of products to it...
FSD Pharma to initiate Phase 1 safety trials for its lead drug candidate PP 101 micro-PEA in 1Q 2020
With over $70 million in cash and assets, it has enough financial muscle to transform into a specialty pharmaceutical R&D company PP 101 is the fi...
Over 100 Australian doctors and 200 patients have been enrolled in the observational study. Patients participating in the study have reported a reduct...
The company reported revenue of $5.2 million in the fourth quarter and $18.1 million for the full fiscal year 2019 The company's subsidiary, Infused M...
